accepted
on 21 Apr 2022
Last Applicant/ Owned by
GASTON GEENSLAAN 1
HEVERLEE
BE
3001
Serial Number
85318930 filed on 12th May 2011
Registration Number
4834268 registered on 20th Oct 2015
Correspondent Address
Clifford D. Hyra
Filing Basis
1. intent to use
Disclaimer
NO DATA
Color is not claimed as a feature of the mark. Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, [ cardiac, ] inflammation, [ hypertension, immune system, blood and cancer ] disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, bloodRead More
Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, [ cardiac, ] inflammation, [ hypertension, immune system, blood and cancer ] disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial research analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies
No 85318930
No Service Mark
No HGEVR-T313US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Dec 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Dec 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 23rd Dec 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 23rd Dec 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 21st Apr 2022 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 21st Apr 2022 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 14th Apr 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 27th Oct 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 20th Oct 2021 | TEAS SECTION 8 RECEIVED |
| 20th Oct 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
